IPAD-DB ID | C01169 |
Name | Cannabigerol (CBG) |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 2 1 H 3 2 O 2 |
Molecular Weight | 316.5 g/mol |
IUPAC Name | 2-[(2E)-3, 7-dimethylocta-2, 6-dienyl]-5-pentylbenzene-1, 3-diol |
InChI | InChI=1S/C21H32O2/c1-5-6-7-11-18-14-20(22)19(21(23)15-18)13-12-17(4)10-8-9-16(2)3/h9, 12, 14-15, 22-23H, 5-8, 10-11, 13H2, 1-4H3/b17-12+ |
InChIKey | QXACEHWTBCFNSA-SFQUDFHCSA-N |
Canonical SMILES | CCCCCC1=CC(=C(C(=C1)O)CC=C(C)CCC=C(C)C)O |
PubChem CID | 5315659 |
DrugBank Accession Number | DB14734 |
CAS Registry Number | 25654-31-3 |
Molecular Weight(Computed by SwissADME) | 316.48 |
Hac(Computed by SwissADME) | 23 |
Volume(Computed by ADMETlab 2.0) | 367.614 |
Density(Computed by ADMETlab 2.0) | 0.86 |
nRing(Computed by ADMETlab 2.0) | 1 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 2 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 8 |
Flexibility(Computed by ADMETlab 2.0) | 1.125 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -3.761 |
LogD(Computed by ADMETlab 2.0) | 4.995 |
logP(Computed by ADMETlab 2.0) | 7.746 |
TPSA(Computed by SwissADME) | 40.46 |
Hbond Acceptor(Computed by SwissADME) | 2 |
Hbond Donor(Computed by SwissADME) | 2 |
Rotatable Bonds(Computed by SwissADME) | 9 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | Yes |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | Yes |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -2.96 |
Lipinski(Computed by SwissADME) | 1 |
Ghose(Computed by SwissADME) | 1 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 1 |
Muegge(Computed by SwissADME) | 1 |
Bioavailability Score(Computed by SwissADME) | 0.55 |